Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Randomized, Active Control Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

NCT05204394 is registered in ClinicalTrials.gov with Viriom as lead sponsor.

NCT NCT05204394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Randomized, Active Control Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy
Lead sponsor
Viriom
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 1, 2022
Completion date
October 16, 2023
Enrollment
438 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection